Instrument Inactif

Autres langues BIOLASE Inc Nasdaq

Actions

US0909111082

Sociétés holdings

Autres langues

14/10/25	BIOLASE Showcases Breakthrough YSGG Laser Protocol for Predictable Periodontitis Treatment at AAP 2025
27/08/25	MegaGen Implant Co., Ltd. acquired All Assets of BIOLASE, Inc from BIOLASE, Inc. (OTCPK:BIOL.Q).
19/05/25	EnVVeno Medical Names Jennifer Bright CFO
05/03/25	Motion for Asset Sale Approved for BIOLASE, Inc.
25/02/25	Second Amended Combined Liquidation Plan & Disclosure Approved for BIOLASE, Inc.
21/02/25	Second Amended Combined Liquidation Plan & Disclosure Statement Filed by BIOLASE, Inc.
18/02/25	Motion for Exclusivity Period Extension Approved For BIOLASE, Inc.
14/02/25	Motion for Asset Sale Filed by BIOLASE, Inc.
29/01/25	First Motion for Exclusivity Period Extension Filed by BIOLASE, Inc.
14/01/25	First Amended Disclosure Statement Approved on Interim Basis for BIOLASE, Inc.
13/01/25	First Amended Combined Liquidation Plan and Disclosure Statement Filed by BIOLASE, Inc.
08/01/25	Disclosure Statement Conditionally Approved for BIOLASE, Inc.
23/12/24	Combined Liquidation Plan and Disclosure Statement Filed by BIOLASE, Inc.
15/11/24	Motion for Asset Sale Approved for BIOLASE, Inc.
15/11/24	Final DIP Financing Approved for BIOLASE, Inc.
08/11/24	Biolase: Q3 Earnings Snapshot
08/11/24	BIOLASE : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)
07/11/24	BIOLASE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
04/11/24	Sonendo, Inc. cancelled the acquisition to acquire Substantially All Assets of BIOLASE, Inc. from BIOLASE, Inc..
17/10/24	Bidding Procedure Approved for BIOLASE, Inc.
03/10/24	Interim DIP Financing Approved for BIOLASE, Inc.
02/10/24	Motion for Joint Administration Approved for BIOLASE, Inc.
01/10/24	Biolase Begins Chapter 11 Bankruptcy, Court-Supervised Sale
01/10/24	BIOLASE : Voluntarily Initiates Chapter 11 Proceedings Form 8 K
01/10/24	Motion for Asset Sale Filed by BIOLASE, Inc.